Since ALT elevation corresponds to the severity of NAFLD, we also investigated NAFLD assessed by FLI (≥ 60) with elevated ALT levels (> 33 IU/L for males and > 25 IU/L for females) [20] as a surrogate marker for NASH. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatohepatitis.